Real-world events trump virtual gatherings
From virtual dance parties and raves to virtual happy hours and potlucks – online gatherings reached new heights during COVID-19, helping individuals stay connected during lockdowns. While it’s… read more.
From virtual dance parties and raves to virtual happy hours and potlucks – online gatherings reached new heights during COVID-19, helping individuals stay connected during lockdowns. While it’s… read more.
Weight loss via intermittent energy restriction (IER) results in changes in the brain and in the gut, according to scientists in China. IER involves days of relative fasting… read more.
An unprecedented resurgence in invasive meningococcal disease followed the lifting of pandemic restrictions in France, according to a paper published in the Journal of Infection and Public Health… read more.
The European Medicines Agency, the EU drug watchdog, has approved the first medicine using CRISPR/Cas9, a novel gene-editing technology. Casgevy (exagamglogene autotemcel) is indicated for the treatment of… read more.
Artery calcification is almost twice as common in people who stay up late, according to a study from the University of Gothenburg, Sweden. The scientists found that circadian function… read more.
Artificial intelligence (AI) will play a role in drug development, including the way in which medicines are regulated, according to European experts. The European Medicines Agency (EMA) and… read more.
A total of seventy-seven new medicinal products were approved in Europe last year, seven of which were given the green light in December. At European level, the EMA’s… read more.
Young people who have used e-cigarettes are more than twice as likely to report experiencing chronic stress, according to research Dr Teresa To from the Hospital for Sick… read more.
The cells of babies exposed to air pollution while in the womb show damage which may put them at risk of ill-health later in life, according to research… read more.
Survival rates for men with metastatic prostate cancer have increased by an average of six months, something which coincides with the gradual introduction of ‘dual treatment’ since 2016,… read more.
The European Medicines Agency (EMA) has recommended seven medicines for approval at its October 2023 meeting. The brings the total number of newly approved medicines this year to… read more.
The European Medicines Agency (EMA) has adopted revised transparency rules for the publication of information on clinical trials submitted through the Clinical Trials Information System (CTIS). The changes give access… read more.